February 17, 202100:05:47

Matt Wolf, leader of the healthcare valuation process and a Senior Analyst at RSM on How COVID Has Changed Private Equity Deals 2-17-21

This episode features Matt Wolf, leader of the healthcare valuation process and a Senior Analyst at RSM.  Here, he discusses how private equity deals have changed through COVID, the virtualization of private equity, and more.

No transcript available.